About
HemoGenyx LLC is developing a revolutionary new treatment for blood diseases, such as leukemia and lymphoma. We leverage a special class of cells, which can generate cancer-free blood stem cells. Our therapy will dramatically increase the efficacy of bone marrow transplants and eliminate the need for bone marrow donors. HemoGenyx LLC addresses three key problems: 1. The dearth of effective treatments for blood cancers, such as leukemia and lymphoma; 2. The high failure rate of bone marrow transplants. Fifty percent of all bone marrow transplants fail due to the body’s rejection of the transplant, complications from the procedure, or a relapse of the disease; and 3. The acute shortage of bone marrow donors. Seventy percent of all patients who need a bone marrow transplant from a donor are unable to have one because a match is unavailable. HemoGenyx LLC leverages AHE cells which can generate cancer-free blood stem cells to treat blood cancers with superior results.